LYTIR

Insider · SEC Form 4 · CEO and President

Murdoch Travis

In the 12 months to Nov 8, 2026, on the open market: bought $1.5M of BRVE. Filed 0 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. BRVEBought: Braveheart Bio, Inc. Aug 7, 2026 83,333 shares filed Aug 7, 2026 2,940,670 shares held directly after, as filed filing $1.5M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.